ClassID:

170381

G01N2333/4722 - CPC Classification

Classification description:

Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates; Assays involving proteins of known structure or function as defined in the subgroups; Details Proteoglycans, e.g. aggreccan

Recent Application in this class:
#1
20250369986
2025-12-04

APPLICATION OF BIOMARKER IN PREPARING METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE CLASSIFICATION PRODUCTS

#2
20250232875
2025-07-17

CMYBPC MARKER COMBINATIONS FOR EARLY DISCRIMINATION OF TYPE 2 VERSUS TYPE 1 ACUTE MYOCARDIAL INFARCTION

#3
20250188467
2025-06-12

CANCER STEM CELL MARKER AND CANCER STEM CELL TARGETING DRUG

#4
20250179211
2025-06-05

Antibodies and antibody fragments and analogues specific for chondroitin sulfate

#5
20240230676
2024-07-11

ESM1 MARKER PANELS FOR EARLY DETECTION OF SEPSIS

#6
20240230669
2024-07-11

COMPOSITIONS AND METHODS FOR TREATING EYE INFECTIONS AND DISEASE

#7
20240192227
2024-06-13

METHODS OF DIAGNOSING AND PREDICTING RENAL DECLINE

#8
20240094210
2024-03-21

METHOD FOR TREATING SOLUBLE GPC3-CONTAINING SPECIMEN IN SOLUBLE GPC3 IMMUNOASSAY

#9
20230349926
2023-11-02

METHODS, COMPOSITIONS, AND KITS FOR DETECTING AND MEASURING ENDOTHELIAL INJURY IN NORMAL AND DISEASED HUMAN CENTRAL NERVOUS SYSTEM (CNS)

#10
20230296629
2023-09-21

A DIAGNOSTIC BLOOD TEST METHOD FOR THE DETECTION OF ALZHEIMER'S DISEASE

#11
20220119857
2022-04-21

Use of Muramic Acid as a Biomarker for Gastrointestinal Peptidoglycan Hydrolysis

#12
20210405048
2021-12-30

Diagnosing Sepsis or Bacteremia by Detecting Peptidoglycan Associated Lipoprotein (PAL) in Urine

#13
20210364533
2021-11-25

Diagnosis method of multiple sclerosis

#14
20210317453
2021-10-14

CANCER STEM CELL MARKER AND CANCER STEM CELL TARGETING DRUG

#15
20210231684
2021-07-29

COMPOSITIONS AND METHODS FOR TREATING EYE INFECTIONS AND DISEASE

#16
20200174017
2020-06-04

COMPOSITIONS AND METHODS FOR TREATING EYE INFECTIONS AND DISEASE

#17
20200115756
2020-04-16

METHOD FOR DIAGNOSIS OF UNSTABLE ATHEROSCLEROTIC PLAQUES

#18
20190249156
2019-08-15

Methods of generating and screening for lytic chimeric polypeptides

#19
20190161799
2019-05-30

Marker and Method for Determining the Composition or Purity of a Cell Culture and for Determining In Vitro the Identity of a Cartilage Cell or Synovial Cell

#20
20190024132
2019-01-24

D-ALA-D-ALA-BASED DIPEPTIDES AS TOOLS FOR IMAGING PEPTIDOGLYCAN BIOSYNTHESIS

#21
20180312602
2018-11-01

ANTI-GPC3 ANTIBODIES AND IMMUNOCONJUGATES

#22
20180256680
2018-09-13

H3T3A mutant protein efficiently reduces H3T3P and causes increased cell death of rapidly dividing cells

#23
20180243451
2018-08-30

RADIOLABELED ANTI-GLYPICAN-3 IMMUNOCONJUGATES FROM IMMUNO-PET IMAGING OF HEPATOCELLULAR CARCINOMA

#24
20180217162
2018-08-02

Biomarkers of myocardial injury

#25
20180072811
2018-03-15

Anti-CSPG4 reagents and methods of treating cancer

#26
20170322227
2017-11-09

Compositions and methods for treating eye infections and disease

#27
20170260259
2017-09-14

Monoclonal antibody against muramyl peptides

#28
20170198055
2017-07-13

Diagnostic and therapeutic tool for cancer

#29
20170176457
2017-06-22

Compositions and methods for treating eye infections and disease

#30
20170010270
2017-01-12

Method for assaying soluble GPC3 protein

#31
20160376657
2016-12-29

METHOD OF DIAGNOSING RENAL DISORDERS

#32
20160289326
2016-10-06

Therapeutic and diagnostic methods for manipulating phagocytosis through calreticulin and low density lipoprotein-related receptor

#33
20160274126
2016-09-22

BIOMARKERS FOR THE DIAGNOSIS OF INTERSTITIAL CYSTITIS

#34
20160137993
2016-05-19

Methods of generating and screening for lytic chimeric polypeptides

#35
20160017049
2016-01-21

Anti-GPC3 antibodies and immunoconjugates

#36
20160000946
2016-01-07

RADIOLABELED ANTI-GLYPICAN-3 IMMUNOCONJUGATES FOR IMMUNO-PET IMAGING OF HEPATOCELLULAR CARCINOMA

#37
20150344547
2015-12-03

Monoclonal antibody against muramyl peptides

#38
20150290308
2015-10-15

Monoclonal antibodies for CSPG4 for the diagnosis and treatment of basal breast carcinoma

#39
20150285806
2015-10-08

GPC3-targeting drug which is administered to patient responsive to GPC3-targeting drug therapy

#40
20150253332
2015-09-10

Isotopically labeled glycans and methods for producing the same

#41
20150198598
2015-07-16

Kit for diagnosing malignant melanoma

#42
20150132782
2015-05-14

Method for diagnosing cancer by detecting GPC3

#43
20150087589
2015-03-26

Genes and proteins associated with angiogenesis and uses thereof

#44
20150038778
2015-02-05

ITIH5 AS A DIAGNOSTIC MARKER OF UTERINE DEVELOPMENT AND FUNCTIONAL DEFECTS

#45
20150031057
2015-01-29

METHOD FOR THE DETERMINATION OF RENAL FUNCTION

#46
20130338102
2013-12-19

Methods and compositions for detection of microbial contaminants in peritoneal dialysis solutions

#47
20130288926
2013-10-31

Methods of generating and screening for lytic chimeric polypeptides

#48
20130288914
2013-10-31

Method of determining administration effect in cancer chemotherapy with S-1

#49
20130273570
2013-10-17

Method for identification and culture of multipotent mesenchymal stem cells with high proliferation potential

#50
20130210017
2013-08-15

Methods of determining chondrocytes

#51
20130078246
2013-03-28

Fibronectin aggrecan biomarker for the identification of spinal and joint source of pain

#52
20130004978
2013-01-03

Anti-LG3 antibodies and uses thereof

#53
20120329051
2012-12-27

METHODS OF EVALUATING CELLS AND CELL CULTURES

#54
20120283188
2012-11-08

Genes and proteins associated with angiogenesis and uses thereof

#55
20120207737
2012-08-16

MEDICAL UTILITY OF GLYCAN-BINDING PROTEINS AND GLYCANS

#56
20120149013
2012-06-14

METHODS OF EVALUATING CELLS AND CELL CULTURES

#57
20120088689
2012-04-12

METHOD OF DIAGNOSING RENAL DISORDERS

#58
20110171229
2011-07-14

Monoclonal antibodies for CSPG4 for the diagnosis and treatment of basal breast carcinoma

#59
20110165591
2011-07-07

USE OF BIGLYCAN IN THE ASSESSMENT OF HEART FAILURE

#60
20100273180
2010-10-28

DECORIN POLYPEPTIDE AND METHODS AND COMPOSITIONS OF USE THEREOF

#61
20100098684
2010-04-22

Kits for biomarker detection and treatment selection

#62
20100087362
2010-04-08

USE OF BIGLYCAN OR ENHANCERS OF BIGLYCAN ACTIVITY IN THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS

#63
20100056990
2010-03-04

Methods and compositions for detection of microbial contaminants in peritoneal dialysis solutions

#64
20100021934
2010-01-28

Perlecan fragments as biomarkers of bone stromal lysis

#65
20100004171
2010-01-07

Therapeutic Methods for Neuropathic Pain

#66
20090291462
2009-11-26

Detection or Quantification of Aggrecan and its Fragments

#67
20090239819
2009-09-24

PERITONEAL DIALYSIS SOLUTION TEST METHOD

#68
20090239238
2009-09-24

METHODS FOR MEASURING PRO-INFLAMMATORY SUBSTANCE LEVELS IN DIALYSIS SOLUTIONS AND DIALYSIS COMPONENTS

#69
20090202517
2009-08-13

AGENTS FOR IMPROVING INFLAMMATORY BOWEL DISEASE

#70
20090202514
2009-08-13

AGENTS FOR IMPROVING CHRONIC OBSTRUCTIVE PULMONARY DISEASES

#71
20090130693
2009-05-21

NOVEL BIOMARKERS FOR DIAGNOSIS AND/OR PROGNOSIS OF NEOPLASIAS IN ANIMALS

#72
20090117595
2009-05-07

PRIMARY CENTRAL NERVOUS SYSTEM TUMOR SPECIFIC BEHAB ISOFORMS

#73
20090111095
2009-04-30

Diagnostic kit for malignant melanoma

#74
20080248481
2008-10-09

Methods of evaluating cells and cell cultures

#75
20080153114
2008-06-26

METHODS, COMPOSITIONS, AND KITS FOR THE DETECTION OF BACTERIA IN A SAMPLE

#76
20080057516
2008-03-06

Receptor for GDNF family ligands

#77
20080003180
2008-01-03

Aging biomarker

#78
20070243214
2007-10-18

Genes and proteins associated with angiogenesis and uses thereof

#79
20070021496
2007-01-25

Methods and compositions for diagnosing and treating arthritic disorders and regulating bone mass

#80
20060263842
2006-11-23

Methods and compositions for detection of microbial contaminants in peritoneal dialysis solution

#81
20060166290
2006-07-27

Primary central nervous system tumor specific BEHAB isoforms

#82
20060084064
2006-04-20

Endocan compositions and methods for the treatment of neoplasms

#83
20060051819
2006-03-09

Detection, evaluation and treatment for advanced prostate cancer

#84
20060014227
2006-01-19

Methods, compositions, and kits for the detection of bacteria in a sample

#85
20060014223
2006-01-19

Method for diagnosing cancer by detecting gpc3

#86
20050191717
2005-09-01

Methods and compositions for detection of microbial contaminants in peritoneal dialysis solutions